Starling Oncology, Inc. Payments of Debt Issuance Costs
Starling Oncology, Inc. (STLN) reported Payments of Debt Issuance Costs of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2024-03-28
- Starling Oncology, Inc. payments of debt issuance costs for the quarter ending 2023-12-31 was $0.00.
- Starling Oncology, Inc. payments of debt issuance costs for the quarter ending 2022-12-31 was $0.00.
- Starling Oncology, Inc. payments of debt issuance costs for the quarter ending 2021-12-31 was $0.00.
- Starling Oncology, Inc. payments of debt issuance costs for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Starling Oncology, Inc. payments of debt issuance costs for fiscal 2022 was $3.66M.
- Starling Oncology, Inc. payments of debt issuance costs for fiscal 2021 was $0.00.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 10-K · filed 2024-03-28 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.66M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $3.66M 10-Q · filed 2023-11-08 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $0.00 10-K · filed 2023-03-16 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |